There is an independent association between perceived stress and both prevalent and incident cognitive impairment, according to a study published online March 7 in JAMA Network Open.
Mar 9, 2023
0
17
According to a study published American Journal of Roentgenology (AJR), percent insular ribbon infarction (PIRI) complements current stroke outcome predictors, classifying patients with slowly progressive stroke who could ...
Feb 15, 2023
0
23
People with a higher cumulative estrogen exposure throughout their life may have a lower risk of stroke, according to a new study published in the February 1, 2023, online issue of Neurology. The lower risk was found for ...
Feb 1, 2023
0
28
A new research paper titled "Impact of COVID-19 on the management of patients with metastatic melanoma" has been published in Oncotarget.
Jan 11, 2023
0
39
Prior infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is not associated with death, major adverse cardiovascular events, or rehospitalization following elective major noncardiac surgery, according ...
Dec 16, 2022
0
8
Risk of death and 12-month mortality among critically ill patients admitted to the intensive care unit are higher for Indigenous than non-Indigenous people, according to research published today by the Medical Journal of ...
Nov 21, 2022
0
19
A study of essential and frontline workers in six U.S. states who tested positive for COVID-19 and received two or three mRNA vaccine doses before delta infections and three doses before omicron infections suggests that they ...
Oct 19, 2022
0
71
The Family Heart Foundation, a leading research and advocacy organization, has shared results from an analysis of patients in its CASCADE FH Registry showing that children with homozygous familial hypercholesterolemia (HoFH) ...
Oct 11, 2022
0
6
The highly selective RET inhibitor selpercatinib was well-tolerated and achieved durable objective responses across multiple tumor types in the Phase I/II LIBRETTO-001 trial, according to researchers from The University of ...
Sep 13, 2022
0
20
A Phase II clinical trial of poziotinib for non-small cell lung cancer (NSCLC) with epidermal growth factor receptor (EGFR) exon 20 mutations, led by researchers at The University of Texas MD Anderson Cancer Center, found ...
Jul 11, 2022
0
6
